A Benefit Risk Review of Pediatric Use of Hydrocodone/Chlorpheniramine, a Prescription Opioid Antitussive Agent for the Treatment of Cough.

Author: BentzJürgen W G, JonesAlphia, MadukaChidi, SloanVictor S

Paper Details 
Original Abstract of the Article :
Hydrocodone/chlorpheniramine is a prescription opioid licensed in the USA for the relief of cough and upper respiratory symptoms associated with allergy or cold in adults, previously contraindicated in children aged < 6 years. We present findings from a modern benefit risk review of hydrocodone/chlo...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520422/

データ提供:米国国立医学図書館(NLM)

Hydrocodone/Chlorpheniramine: A Re-evaluation of Its Role in Pediatric Cough Treatment

The use of [opioids] in children has always been a topic of careful consideration. This research delves into the benefit-risk profile of hydrocodone/chlorpheniramine, a prescription opioid used for cough relief. The authors conducted a comprehensive [benefit-risk review] based on a thorough examination of the manufacturer's pharmacovigilance database and scientific literature. They found no robust evidence of efficacy in treating cough in children aged 6 to 18 years. Furthermore, the review identified a concerning number of serious adverse events, including fatalities. This study highlights the need for a cautious approach to opioid use in children and the importance of ongoing reevaluation of older drugs.

Opioids and Children: A Complex Equation of Benefits and Risks

The results of this study emphasize the importance of weighing the potential benefits against the risks when considering opioid use in children. It's like navigating a desert with hidden dangers, where each step must be carefully considered. This research suggests that the risks associated with hydrocodone/chlorpheniramine outweigh any potential benefits for treating cough in children.

The Value of Proactive Re-evaluation: Ensuring Patient Safety

This study serves as a powerful reminder of the importance of [proactive re-evaluation] of older drugs. As our understanding of drug safety and efficacy evolves, it is crucial to revisit established practices. This is like a camel caravan periodically checking its supplies to ensure a safe journey through the desert. By staying vigilant and continuously assessing the evidence, we can ensure the safety and well-being of patients.

Dr.Camel's Conclusion

This research underscores the importance of evidence-based medicine and continuous reevaluation of drug safety. It's like a wise camel guide leading a caravan through a treacherous desert, ensuring the safety and well-being of all travelers. By staying informed and adapting to new discoveries, we can navigate the complexities of healthcare and make informed decisions for patient well-being.

Date :
  1. Date Completed n.d.
  2. Date Revised 2020-09-30
Further Info :

Pubmed ID

31073977

DOI: Digital Object Identifier

PMC6520422

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.